Functional Food Application of Okara Protein Hydrolysate (OPH)- for Anti-exercise-fatigue

Chung Shan Medical University

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Okara protein hydrolysate (OPH)

Study type

Interventional

Funder types

Other

Identifiers

NCT05000918

CS2-20042

Details and patient eligibility

About

The aim of this study is to investigate the anti-exercise-fatigue effects of okara protein hydrolysate (OPH) in men

Full description

Each subject must undergo a cardiopulmonary capacity test to assess the maximum oxygen uptake 1 week before the intervention (day 1), and then eat the test food for 4 weeks (day 8 to day 35). Before and after the intervention (the 8th and 35th day), posture measurement, diet questionnaire survey and endurance exercise ability test were carried out. The trial period was 35 days. The subjects will take blood samples before, during, after, and 30 minutes and 60 minutes after the end of the two endurance exercise tests. During the whole period of participating in the program, blood will be collected 10 times, each with a blood volume of 15 mL. Gas is collected during the period and within 1 hour after exercise. Gas is collected every 15 minutes and 1 minute at a time. Analyze his exercise time, oxygen intake and blood biochemical value.

Enrollment

18 patients

Sex

Male

Ages

20 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

The subject is a male and aged 20-40.
The subject has a usual exercise habit (exercising 2 times or more per week) and did not participate in professional sports competitions or professional sports training during the study period.
No smoking or drinking habits.
No food allergies and the liver function is normal.
No cardiovascular diseases or other chronic diseases, and no serious illnesses requiring hospitalization during the study period.
The subject can understand the test process described in the consent form and the possible potential risks and benefits, and can sign the consent form.
The subject can accept dietary control during the trial period.

Exclusion criteria

Those who have taken nutritional supplements containing branched-chain amino acids.
Those who cannot complete the endurance exercise ability test.
Those who are diagnosed with kidney disease, heart disease, or cancer and are still under active treatment.
Have used other drugs, whose pharmacological effects may affect fatigue.
Subjects who have systemic infections and require systemic antibiotics.